TSC22D3 as an immune-related prognostic biomarker for acute myeloid leukemia.

Li, Yang; Huang, Hanying; Zhu, Ziang; Chen, Shuzhao; Liang, Yang; Shu, Lingling

Li, Yang; Huang, Hanying; Zhu, Ziang; Chen, Shuzhao; Liang, Yang; Shu, Lingling.

Afiliação

Li Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Huang H; Department of Hematological Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Zhu Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Chen S; Department of Hematological Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Liang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Shu L; Department of Hematological Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.

iScience ; 26(8): 107451, 2023 Aug 18.

Article em En | MEDLINE | ID: mdl-37575189

Palavras-chave

Cancer systems biology; Components of the immune system; Functional aspects of cell biology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: IScience Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google